Real-World Evaluation of Treatment Pattern, Time to Next Treatment (TTNT), Health Care Resource Utilization (HCRU), and Cost of Care in Follicular Lymphoma (FL)

被引:0
|
作者
Gaballa, Sameh [1 ]
Xue, Mei [2 ]
Chuang, Po-Ya [3 ]
Esselman, Kaitlyn [3 ]
Furnback, Wesley [3 ]
Yang, Keri [2 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] BeiGene USA Inc, San Mateo, CA USA
[3] Real Chem Inc, New York, NY USA
来源
关键词
IBCL; follicular lymphoma; treatment line; health care resource; utilization; treatment costs; real-world evidence;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IBCL-516
引用
收藏
页码:S500 / S501
页数:2
相关论文
共 50 条
  • [11] Real-world practice patterns in follicular lymphoma (FL) care at community oncology centers.
    Barr, Paul M.
    Patel, Taral
    Dela Cruz, Servillano E.
    Hussein, Maen A.
    Castine, Michael J.
    Farris, Breanne Y.
    Crawford, Rebecca R.
    Carter, Jeffrey D.
    Sapir, Tamar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [12] Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma
    Tadrous, Mina
    Khuu, Wayne
    Lebovic, Gerald
    Stanbrook, Matthew B.
    Martins, Diana
    Paterson, J. Michael
    Mamdani, Muhammad M.
    Juurlink, David N.
    Gomes, Tara
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (01) : 59 - +
  • [13] Real-world treatment patterns and health care utilization in patients with prurigo nodularis
    Huang, Amy H.
    Canner, Joseph K.
    Khanna, Raveena
    Williams, Kyle A.
    Kang, Sewon
    Schmidt, Charles E.
    Kwatra, Shawn
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB78 - AB78
  • [14] Time to Next Treatment, Health Care Resource Utilization, and Costs Associated with Ibrutinib Use Among US Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Real-World Retrospective Analysis
    Huang, Qing
    Borra, Sujana
    Li, Jieni
    Wang, Li
    Shrestha, Sulena
    Sundaram, Murali
    Janjan, Nora
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10): : 1266 - 1275
  • [15] Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma
    O'Sullivan, Dylan E.
    Boyne, Devon J.
    Syed, Iqra A.
    Shephard, Cal S.
    Clouthier, Derek L.
    Yoshida, Eric M.
    Spratlin, Jennifer L.
    Batra, Atul
    Rigo, Rodrigo
    Hannouf, Malek
    Hu, Xun Yang
    Jarada, Tamer N.
    Brenner, Darren
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [16] Real-world treatment patterns, clinical outcomes, and health care resource utilization in advanced unresectable hepatocellular carcinoma
    O'Sullivan, Dylan E.
    Boyne, Devon J.
    Syed, Iqra A.
    Shephard, Cal
    Clouthier, Derek L.
    Yoshida, Eric M.
    Spratlin, Jennifer L.
    Batra, Atul
    Rigo, Rodrigo
    Hannouf, Malek
    Hu, Xun Yang
    Jarada, Tamer
    Brenner, Darren R.
    Cheung, Winson Y.
    CANADIAN LIVER JOURNAL, 2022, 5 (04): : 476 - 492
  • [17] The real-world cost and health resource utilization associated to the CNIC-polypill compared to usual care
    Cordero, A.
    Gonzalez-Juanatey, J. R.
    Castellano, J. M.
    Masana, L.
    Dalmau, R.
    Ruiz Olivar, J. E.
    Fuster, V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2545 - 2545
  • [18] TREATMENT PATTERNS AND HEALTH CARE COSTS IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
    Clancy, Z.
    Bell, E.
    Chastek, B.
    Bunner, S.
    Copher, R.
    Arekapudi, S.
    VALUE IN HEALTH, 2020, 23 : S43 - S43
  • [19] REAL-WORLD COSTS AND HEALTH CARE RESOURCE UTILIZATION (HCRU) AMONG PATIENTS WITH TRIPLECLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN THE US
    Chari, A.
    Nair, S.
    Lin, X.
    Slavcev, M.
    Marshall, A.
    Potluri, R.
    Kumar, S.
    VALUE IN HEALTH, 2022, 25 (12) : S101 - S102
  • [20] HEALTH CARE RESOURCE UTILIZATION AND COST IN PARKINSON'S DISEASE PATIENTS IN A REAL-WORLD SETTING IN QUEBEC, CANADA
    Baribeau, V
    Mohammed, S.
    Awan, A.
    Parison, D.
    Lachaine, J.
    VALUE IN HEALTH, 2023, 26 (12) : S58 - S58